Skip to content

Effect of method of cardiac arresting on outcomes following bypass surgery

Comparison of simultaneous antegrade.venous graft cardioplegia infusion to conventional method in coronary artery bypass grafting

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017102625488N2
Enrollment
178
Registered
2017-11-04
Start date
2017-11-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Coronary artery disease. Condition 2: Coronary artery bypass graft. Atherosclerotic heart disease Mechanical complication of coronary artery bypass and valve grafts

Interventions

Intervention 1: Intervention group: Mostly crystalloid cardioplegia (2% blood to prevent obscuring of the operative field), is infused continuously through vein grafts by a separate infusion set, onc
Treatment - Surgery
Control group: Antegrade cold blood cardioplegia (at a ratio of 4 to 1) is infused via aortic root by means of a cannula inserted by the surgeon at the middle part of ascending aorta. This injection c
Intervention group: Mostly crystalloid cardioplegia (2% blood to prevent obscuring of the operative field), is infused continuously through vein grafts by a separate infusion set, once each distal an

Sponsors

Vice chancellor for research and technology, Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Coronary artery disease patients scheduled for first-time elective isolated on-pump CABG Exclusion criteria: 1. Redo CABG 2. Urgent CABG 3. Off-pump CABG 4. Combined operations including CABG in addition to valve repair or replacement 5. Unexpected intra-operative complications e.g. aortic rupture during cannulation

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The need for balloon pump. Timepoint: During and after weaning. Method of measurement: Number (percentage).;The need for inotrope. Timepoint: During and after weaning. Method of measurement: Number (percentage).

Secondary

MeasureTime frame
Other complications including neurologic, renal, and pulmonary complications. Timepoint: Within one month after surgery. Method of measurement: Number (percentage).;The amount of bleeding. Timepoint: Within 24 hours following surgery. Method of measurement: mL.;Serum level of potassium. Timepoint: Immediately upon arrival to ICU. Method of measurement: mEq/L.;The rate of perioperative myocardial infarction. Timepoint: During hospitalization. Method of measurement: Number (percentage).;Hospital mortality. Timepoint: During hospitalization. Method of measurement: Number (percentage).;The rate of postoperative arrhythmia. Timepoint: During ICU stay. Method of measurement: Number (percentage).;Peak serum level of CK, CK-MB, and cTnI. Timepoint: At 12 hours following operation in the ICU. Method of measurement: mcg/L.;The rate of superficial or deep wound infection. Timepoint: During hospitalization. Method of measurement: Number (percentage).;The rate of re-exploration due to hemorrhage or tamponade. Timepoint: Within 24 hours following surgery in the ICU. Method of measurement: Number (percentage).;Ventilation time. Timepoint: Within 24 hours following surgery in the ICU. Method of measurement: Hours.;Arterial level of base excess (BE). Timepoint: Within one hour after arrival to ICU. Method of measurement: mmol/L.;Duration of ICU stay. Timepoint: following surgery. Method of measurement: Days.;Duration of hospital stay. Timepoint: following surgery. Method of measurement: Days.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehrzad Sharifi

Arak University of Medical Sciences

m.sharifi@arakmu.ac.ir+98 86 3417 3602

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026